Commercial success of Stelara, however, could hinge on acceptance by dermatologists. Which TNF-alpha inhibitor has the most to lose if Stelara changes prescribing habits—Humira or Enbrel? To find out, continue reading at BNET Pharma….
Editor David J Phillips does not hold a financial interest in any stocks mentioned in this article. The 10Q Detective has a Full Disclosure Policy.